The tumor-secreted cGAMP or DNA is transported to antigen presenting cells (APCs), such as dendritic cell (DC) and macrophage, and then activates the STING-induced type I IFN signaling pathway, finally triggering the anti-tumor immune response mediated by CD8+ T cells or NK cells11,12. This evidence concerns the gene CD8A and neoplasm.